The Undy 5000, created by the CCA, stresses the importance of timely colon cancer screening and also provides valuable information for those already affected by the disease. The CCA and Dulcolax are very excited to have local CVS pharmacy stores partnering to raise awareness of colon cancer. Undy 5000 sign-up information can be found in local Dallas CVS stores.
The makers of Dulcolax®* are the proud presenting sponsor of the 2011 Undy 5000 races. A portion of the proceeds from Dulcolax product purchases supports Colon Cancer Alliance community screening programs. As the #1 doctor recommended laxative brand**, Dulcolax reminds everyone over the age of 50 or with a family history of colon cancer, that a colonoscopy can save lives.
"We love coming to Dallas," said Andrew Spiegel, Chief Executive Officer of the Colon Cancer Alliance. "This is our fourth race here, and I fully expect this year's Dallas Undy to shatter participation and fundraising records!"
More information about the Undy 5000 is available online at www.undy5000.org.
Created by the CCA in 2008, the Undy 5000 stresses the importance of timely colon cancer screenings, early detection, and provides valuable information for those already affected by the disease. Event proceeds help fund the CCA's patient support and public awareness programs. Part of the proceeds will also be left behind to help fund colon cancer support services at Mary Crowley Cancer Research Center.
About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelh
|SOURCE Boehringer Ingelheim Pharmaceuticals, Inc. and Colon Cancer Alliance|
Copyright©2010 PR Newswire.
All rights reserved